9189226

Source:http://linkedlifedata.com/resource/pubmed/id/9189226

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0020971, umls-concept:C0205195, umls-concept:C0205210, umls-concept:C0920321
pubmed:issue	7
pubmed:dateCreated	1997-8-13
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8710219
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/AIDS Vaccines, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Interferon Type I, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, Synthetic
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0269-9370
pubmed:author	pubmed-author:AboulkerJ PJP, pubmed-author:BizziniBB, pubmed-author:CoulaudI PIP, pubmed-author:DescampsDD, pubmed-author:GomardEE, pubmed-author:GougeonM LML, pubmed-author:LebonPP, pubmed-author:ZaguryDD
pubmed:issnType	Print
pubmed:volume	11
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	937-8
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:9189226-AIDS Vaccines, pubmed-meshheading:9189226-Double-Blind Method, pubmed-meshheading:9189226-Drug Combinations, pubmed-meshheading:9189226-HIV Infections, pubmed-meshheading:9189226-Humans, pubmed-meshheading:9189226-Interferon Type I, pubmed-meshheading:9189226-Peptides, pubmed-meshheading:9189226-Recombinant Proteins, pubmed-meshheading:9189226-Vaccines, Synthetic
pubmed:year	1997
pubmed:articleTitle	A placebo-controlled clinical phase I trial with combined anti-HIV-1 and anti-interferon-alpha immunization.
pubmed:publicationType	Letter, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase I